Authors: Kailajarvi, M Ahokoski, O Virtanen, A Salminen, E Irjala, K

Citation: M. Kailajarvi et al., Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests, ANTICANC R, 21(4B), 2001, pp. 2867-2872

Authors: Kailajarvi, M Ahokoski, O Virtanen, A Salminen, E Irjala, K

Citation: M. Kailajarvi et al., Alterations in laboratory test results during adjuvant breast cancer treatment, CLIN CH L M, 38(5), 2000, pp. 443-451

Authors: Kailajarvi, M Ahokoski, O Virtanen, A

Citation: M. Kailajarvi et al., Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids, ANTICANC R, 20(2B), 2000, pp. 1323-1327

Authors: Laine, K Forsstrom, J Gronroos, P Irjala, K Kailajarvi, M Scheinin, M

Citation: K. Laine et al., Frequency and clinical outcome of potentially harmful drug metabolic interactions in patients hospitalized on internal and pulmonary medicine wards: Focus on warfarin and cisapride, THER DRUG M, 22(5), 2000, pp. 503-509

Authors: Kailajarvi, M Takala, T Gronroos, P Tryding, N Viikari, J Irjala, K Forsstrom, J

Citation: M. Kailajarvi et al., Reminders of drug effects on laboratory test results, CLIN CHEM, 46(9), 2000, pp. 1395-1400